Global /Egypt /Healthcare /Drug Manufacturers - General /OCPH

October Pharma S.A.E

OCPH

• EGX: OCPH • Delayed

310.05EGP 5.9%

5.98 USD

As of 5 June 2026, October Pharma S.A.E has a market cap of $71.61M USD, ranking #27956 globally and #116 in Egypt. It ranks #2525 in the Healthcare sector, and #906 in the Drug Manufacturers - General industry.

Global Rank

27956

Country Rank

116

Sector Rank

2525

Industry Rank

906

Key Stats

Market Cap

$71.61MUSD

3.72B EGP

Enterprise Value

$78.68MUSD

4.08B EGP

Revenue (TTM)

$28.14MUSD

1.46B EGP

EBITDA (TTM)

$8.1MUSD

419.64M EGP

Net Income (TTM)

$3.18MUSD

165.09M EGP

EBITDA Margin

29%

Profit Margin

13%

PE Ratio

22.5

PS Ratio

2.5

PB Ratio

5.6

EV/EBITDA

9.7

Company Profile

Country (HQ)

Egypt

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Hesham Abdul Soliman open_in_new

Founded

1987

Website

octoberpharma.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
5.9%	-2.4%	52%	56%	32%	43%	193%	193%	486%

News

Markets

Exchange	Ticker	Price	Quotes
Egyptian Exchange (EGX) MIC: XCAI PRIMARY	OCPH اكتوبر فارما ISIN: EGS380R1C018 Shares Out.: Shares Outstanding: 12.0M¹ Shares Float: 1.408M² TV: TradingView: EGX: OCPH SA: Stock Analysis: EGX: OCPH YF: Yahoo Finance: OCPH GF: Google Finance: EGX: OCPH BA: Barron's: OCPH MS: Morningstar: XCAI: OCPH	310.05 EGP	TV: TradingView: EGX: OCPH SA: Stock Analysis: EGX: OCPH YF: Yahoo Finance: OCPH GF: Google Finance: EGX: OCPH BA: Barron's: OCPH MS: Morningstar: XCAI: OCPH

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About October Pharma S.A.E

October Pharma S.A.E manufactures and sells pharmaceutical products in Egypt. The company provides human medicines in the form of capsules, tablets, suppositories, syrup, and drops for internal and sprays and inhalers for external use. October Pharma S.A.E was incorporated in 1987 is based in Cairo, Egypt.

Similar Companies

Industry: Drug Manufacturers - General (Egypt)

Name	Market Cap (USD) diff.	PE	Country
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) EGX: RMDA	$175.16M 9.1B EGP 145%	34.1	Egypt
MINAPHARM Pharmaceuticals EGX: MIPH	$135.12M 7.02B EGP 89%	58.9	Egypt
EI- Nile Co. for Pharmaceuticals and Chemical Industries EGX: NIPH	$119.53M 6.21B EGP 67%	27.1	Egypt
Kahira Pharmaceuticals & Chemical Industries Co. EGX: CPCI	$90.11M 4.68B EGP 26%	10.0	Egypt
Alexandria Co. For Pharmaceuticals & Chemical Industries EGX: AXPH	$85.99M 4.47B EGP 20%	9.0	Egypt
Memphis Pharmaceuticals & Chemical Industries EGX: MPCI	$74.68M 3.88B EGP 4.3%	7.5	Egypt

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 1M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 764K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 503K%	97.4	United States
Roche Holding AG SIX: RO	$323.4B 256.25B CHF 451K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.25B 215.59B GBP 404K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$276.26B 218.9B CHF 386K%	20.5	Switzerland

chevron_leftBack